Inflazome
is a biotech company that develops and commercializes molecular-targeted drug therapies for the treatment of inflammatory diseases... Read moreInflazome
is a biotech company that develops and commercializes molecular-targeted drug therapies for the treatment of inflammatory diseases... Read more
News
Sep 26, 2020
Seeking Alpha
Inflazome: Roche doubles down on promising inflammation field with Inflazome buy
Sep 22, 2020
PharmaLeaders
Inflazome: Roche acquires Irish biotechnology company Inflazome for 380m
Sep 22, 2020
PharmiWeb
Inflazome: Inflazome announces acquisition by Roche
Sep 21, 2020
SiliconRepublic
Inflazome: Inflazome snapped up in 380m deal with Swiss pharma giant
Sep 21, 2020
Seeking Alpha
Inflazome: Roche acquires Inflazome; shareholders get 380M upfront payment
Sep 21, 2020
PressReleasePoint
Press Release: Inflazome : Goodwin Advises Inflazome on Sale to Roche to Continue Life Sciences M&A Success
Sep 21, 2020
BioPharma Dive
Inflazome: Roche buys Inflazome as pharma interest in targeting inflammation grows
Jul 15, 2020
PharmaLeaders
Inflazome: FDA grants orphan drug designation for Inflazome's Inzomelid to treat cryopyrin-associated periodic syndromes
Mar 25, 2020
BioPortfolio
Inflazome: Inzomelid completes Phase I studies and shows positive results in the treatment of CryopyrinAssociated Periodic Syndrome CAPS
Feb 27, 2020
BioPortfolio
Inflazome: Inflazomes Somalix Demonstrates Positive Safety Tolerability and Pharmacodynamic Profile in its Phase I Study
Inflazome Competitors
1
2
3
4
5
6
7
8
9
10